Yahoo
HKSE - Delayed Quote HKD

Sinopharm Group Co. Ltd. (1099.HK)

15.960 -0.340 (-2.09%)
At close: 4:08:23 PM GMT+8
Chart Range Bar
Loading chart for 1099.HK
  • Previous Close 16.300
  • Open 16.300
  • Bid 15.950 x --
  • Ask 15.900 x --
  • Day's Range 15.830 - 16.330
  • 52 Week Range 14.550 - 22.340
  • Volume 6,747,100
  • Avg. Volume 5,238,201
  • Market Cap (intraday) 49.806B
  • Beta (5Y Monthly) 0.46
  • PE Ratio (TTM) 6.31
  • EPS (TTM) 2.530
  • Earnings Date Oct 26, 2026
  • Forward Dividend & Yield 0.79 (4.85%)
  • Ex-Dividend Date Jun 23, 2026
  • 1y Target Est 20.08

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. Sinopharm Group Co. Ltd. was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

www.sinopharmgroup.com.cn

94,910

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/28/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

1099.HK
13.68%
HANG SENG INDEX (^HSI)
9.89%

1-Year Return

1099.HK
13.28%
HANG SENG INDEX (^HSI)
12.34%

3-Year Return

1099.HK
8.28%
HANG SENG INDEX (^HSI)
32.74%

5-Year Return

1099.HK
7.16%
HANG SENG INDEX (^HSI)
9.63%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 140.77B
Earnings --
Profit Margin 0.00%

Q4

FY24

Q1

FY25

Q2

FY25

Q1

FY26

0
50B
100B
0.0%

Analyst Insights

View More

Analyst Price Targets

17.15
20.08 Average
15.960 Current
24.24 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.25%

  • Return on Assets (ttm)

    2.56%

  • Return on Equity (ttm)

    7.96%

  • Revenue (ttm)

    571.3B

  • Net Income Avi to Common (ttm)

    7.16B

  • Diluted EPS (ttm)

    2.530

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    37.83B

  • Total Debt/Equity (mrq)

    52.93%

  • Levered Free Cash Flow (ttm)

    11.99B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: